These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 3989971
1. [A study of cefoperazone levels in the cerebrospinal fluid of patients with hydrocephalus]. Asahi S, Mori N, Tajika Y, Kagawa M. Jpn J Antibiot; 1985 Jan; 38(1):121-7. PubMed ID: 3989971 [Abstract] [Full Text] [Related]
2. Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy. Wang Q, Wu Y, Chen B, Zhou J. BMC Anesthesiol; 2015 Jan; 15():33. PubMed ID: 25798070 [Abstract] [Full Text] [Related]
3. [Clinical studies of cefoperazone in neurosurgery]. Kitamura K, Shimizu T, Abe H, Suzuki J, Tanaka R, Nagai H, Yamamoto S, Handa H, Nishimoto A, Matsuoka K. Jpn J Antibiot; 1986 Jan; 39(1):63-74. PubMed ID: 2939268 [Abstract] [Full Text] [Related]
4. [Concentration of antibiotics (cefoperazone) in human brain, brain tumor tissue and cerebrospinal fluid]. Ito H, Funaki N, Kitamura Y, Shoin K, Nagatani H, Yamamoto S. No Shinkei Geka; 1984 May; 12(6):681-6. PubMed ID: 6087180 [Abstract] [Full Text] [Related]
5. [The penetration of cefoperazone into the cerebrospinal fluid in patients on acute or chronic stage]. Honda E, Shimamoto H, Hara K, Nishio N. Jpn J Antibiot; 1988 Apr; 41(4):409-14. PubMed ID: 3404651 [Abstract] [Full Text] [Related]
11. [Transfer of injected sulbactam/cefoperazone into burn blister fluid]. Aoyama H, Sugiyama H, Tada M, Okuda J, Izawa Y. Jpn J Antibiot; 1988 Sep; 41(9):1279-84. PubMed ID: 3241326 [Abstract] [Full Text] [Related]
12. [Fundamental and clinical studies of sulbactam/cefoperazone in the pediatric field]. Motohiro T, Tanaka K, Koga T, Shimada Y, Tomita N, Sakata Y, Fujimoto T, Nishiyama T, Ishimoto K, Tominaga K. Jpn J Antibiot; 1984 Oct; 37(10):1898-918. PubMed ID: 6094868 [Abstract] [Full Text] [Related]
13. [Clinical investigation of the biliary excretion of cefoperazone in obstructive jaundice]. Matsumoto T, Moriwaki M, Iizuka Y. Jpn J Antibiot; 1986 Oct; 39(10):2795-802. PubMed ID: 3806961 [Abstract] [Full Text] [Related]
14. [Bacteriological, pharmacokinetic and clinical studies on sulbactam/cefoperazone in the pediatric field]. Fujii R, Meguro H, Arimasu O, Mashiko J, Tajima T, Nonaka C, Nagamatsu I, Sato Y, Honjo T, Watanabe A. Jpn J Antibiot; 1984 Dec; 37(12):2427-56. PubMed ID: 6098739 [Abstract] [Full Text] [Related]
15. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime]. Takeuchi N, Kinukawa T, Matsuura O, Hattori R, Hasegawa S, Ohshima S, Ono Y. Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132 [Abstract] [Full Text] [Related]
16. [Studies on sulbactam/cefoperazone in the field of pediatrics]. Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M. Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865 [Abstract] [Full Text] [Related]
17. [Basic and clinical evaluation of sulbactam/cefoperazone in the field of pediatrics]. Toyonaga Y, Kurosu Y, Nakamura H, Sugita M, Takahashi T, Hori M. Jpn J Antibiot; 1984 Dec; 37(12):2457-77. PubMed ID: 6098740 [Abstract] [Full Text] [Related]